SA Transcripts • Nov. 13, 2014
We currently have no Breaking News on this stock.
EBIO vs. ETF Alternatives
Eleven Biotherapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.
Other News & PR